STAT

OCTOBER 24, 2024

Imagine, for a moment, that you wake up one morning with a debilitating illness that won’t let go. Weeks and months pass, but the crushing fatigue, constant headaches, and aching muscles remain. You can’t think straight. Simply showering or doing the dishes leaves you floored for days at a time, and the unpredictable symptoms — shortness of breath, dizziness, a racing heart — ebb and flow without warning.

364

364

PharmaVoice

OCTOBER 24, 2024

Despite pent up M&A demand, FTC scrutiny has had a chilling effect on pharma’s appetite for striking major deals.

162

162

STAT

OCTOBER 24, 2024

A federal watchdog found that Medicare Advantage insurers collected billions of dollars in dubious payments from Medicare in a single year by using home visits and medical chart reviews to diagnose patients with conditions for which they received no follow-up care.    A report released Thursday by the Office of Inspector General for the Health and Human Services Department concluded that insurers collectively received an estimated $7.5 billion in payments last year from so-called

Medical Records 363

Medical Records 363

The Guardian - Pharmaceutical Industry

OCTOBER 24, 2024

Biotech giant’s alleged comments come as world leaders at Cop16 discuss how to share benefits from genetic code discoveries fairly AstraZeneca has said it may cut jobs at its UK operation if the government enforces a global push to make companies share profits derived from nature’s genetic codes, multiple sources have told the Guardian. The alleged comments from the company came amid a concerted lobbying push by the pharmaceutical industry against the profit-sharing measures.

119

119

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

OCTOBER 24, 2024

For years, it has been a reliable way to cut back on the consumption of cigarettes and sugary drinks: raise taxes on them. So it might seem an obvious tactic to apply to alcohol, which contributes to untold injuries, diseases and deaths in the United States each year. That’s the thinking of advocates and state legislators across the country, who also see it as a way to pull in more revenue.

Hospitals 360

Hospitals 360

BioPharma Dive

OCTOBER 24, 2024

Newly published data show the therapy reduced the rate of swelling attacks in people with hereditary angioedema, but didn't silence questions about its commercial outlook.

120

120

The Pharmacist

OCTOBER 24, 2024

We caught up with the Pharmacist/Pharmacy Team of the Year Award shortlist ahead of this year’s General Practice Awards ceremony to be held on 6 December at the Novotel London West. Nazir Hussain, specialist respiratory pharmacist, is making significant strides in improving respiratory care in the community with a ‘one-stop’ respiratory clinic. Working with the […] The post The GP Awards shortlist: Nazir Hussain, specialist respiratory pharmacist appeared first on The Pharmacist.

102

102

STAT

OCTOBER 24, 2024

LONDON — A coworking space surrounded by the crush of traffic around King’s Cross station is perhaps not the most glamorous digs. But as the site of Flagship Pioneering’s U.K. outpost, it fits. Not far are University College London, the Wellcome Trust, and the Francis Crick Institute. Novo Nordisk and Merck have major hubs nearby, as do Meta and Google.

300

300

The Pharmacist

OCTOBER 24, 2024

The UK medicines regulator has approved a new treatment that can slow Alzheimer’s disease progression, but NICE has said it is too costly for the NHS. Donanemab, produced by Eli Lilly, is used to treat mild cognitive impairment or mild dementia via a monthly infusion and it requires ‘intensive monitoring for serious side effects’. NICE […] The post NICE rules newly-approved Alzheimer’s-slowing drug too costly for NHS appeared first on The Pharmacist.

95

95

STAT

OCTOBER 24, 2024

Blood testing conducted by the Centers for Disease Control and Prevention has confirmed that one person in Missouri with no known exposure to cattle or poultry contracted H5N1 bird flu in August, and a household contact of the individual may also have been infected. But five health workers who went on to develop influenza-like symptoms after caring for the confirmed case were not infected with the virus.

304

304

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

OCTOBER 24, 2024

Denmark's Lundbeck has said that efforts to build its R&D portfolio are on track to deliver four new molecular entities (NMEs) in phase 3 trials in 2026, including an epilepsy drug from its recently announced $2.6 billion takeover of Longboard Pharma.

105

105

STAT

OCTOBER 24, 2024

The venture capital giant General Catalyst has raised an $8 billion fund with $750 million set aside for health care investments as its acquisition of an Ohio safety net hospital undergoes regulatory review. Fund XII consists of $4.5 billion for funds dedicated to seed and growth equity, $1.5 billion for creating new companies, and $2 billion of “separately managed accounts,” the firm said.

Hospitals 295

Hospitals 295

Pharma Times

OCTOBER 24, 2024

danicopan shown to improve haemoglobin levels and reduce anaemia

147

147

STAT

OCTOBER 24, 2024

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. The next referendum on Gilead Sciences’ oft-criticized oncology business is approaching. Circle Nov. 5 on your calendars. That’s when we’ll get the first look at data from a pivotal clinical trial of anito-cel, the personalized, BCMA-directed CAR-T therapy for multiple myeloma being developed under a pa

286

286

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

OCTOBER 24, 2024

UK scheme to tackle "historically low" numbers of people taking part in dementia trials launches with £20m in government funding

121

121

STAT

OCTOBER 24, 2024

Rise and shine, everyone, another busy day is on the way. We can tell because the pace of motor vehicles passing by our window is picking up and the official mascots are busy foraging for their breakfast on the campus grounds. As for us, we are engaged in the usual ritual of brewing cups of stimulation. Our choice today is maple bourbon. Yes, this is for real.

Immunity 257

Immunity Immunization Drug Pricing Drug Development 257

Express Pharma

OCTOBER 24, 2024

Australia’s Therapeutic Goods Administration (TGA) has recently decided not to register lecanemab (Leqembi) for patients with mild cognitive impairment (MCI) or mild dementia of Alzheimer’s disease (AD). Despite lecanemab demonstrating slowing of disease progression in pivotal trials, concerns about its safety profile have led to TGA’s decision. Against this backdrop, Eli Lilly’s donanemab that has been submitted for review in October 2023 could bring new hope to Alzheimer’s patients in Australi

101

101

STAT

OCTOBER 24, 2024

Will an activist investor campaign against Pfizer lead to big changes at the struggling Pharma giant? Why are some experts questioning the regulatory standards used to approve gene therapies for Duchenne muscular dystrophy? What’s the difference between Novo Holdings and Novo Nordisk, and will it impact a $16 billion acquisition of Catalent? And what lies ahead for Robert F.

277

277

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

OCTOBER 24, 2024

This acquisition strengthens Mankind’s leadership in the fertility drug market and grants access to BSV’s R&D-driven biologics and niche products, further solidifying its presence in high-entry barrier segments Mankind Pharma has completed the transaction to acquire 100 per cent stake in Bharat Serums and Vaccines Limited (BSV), for a purchase consideration of Rs 13,768 crores.

Vaccines 100

Vaccines 100

STAT

OCTOBER 24, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. Read an excerpt from each below. “ What Sandoz CEO Richard Saynor is thinking about the 2024 elections ” With all eyes currently on the upcoming U.S. elections, it’s easy to forget that this

Pharmaceutical Companies 262

Pharmaceutical Companies Pharmaceutical Companies 262

The Pharmacist

OCTOBER 24, 2024

We caught up with the Pharmacist/Pharmacy Team of the Year Award shortlist ahead of this year’s General Practice Awards ceremony to be held on 6 December at the Novotel London West. Nazir Hussain, specialist respiratory pharmacist, is making significant strides in improving respiratory care in the community with a ‘one-stop’ respiratory clinic. Working with the […] The post The GP Awards shortlist: Nazir Hussain, specialist respiratory pharmacist appeared first on The Pharmacist.

84

84

STAT

OCTOBER 24, 2024

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. The EMBARK Phase 3 study for Elevidys, Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy,  was published this month  in Nature Medicine. The paper largely reiterates what’s already known about the negative study — Elevidys failed to achieve its primary endpoint of improving ov

280

280

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

OCTOBER 24, 2024

Hyntelo offers cutting-edge AI solutions like GenAI for enhanced customer engagement. Learn how Hyntelo integrates as a Veeva AI Partner.

105

105

STAT

OCTOBER 24, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! If you aren’t already subscribed to DC Diagnosis , the newsletter from our amazing reporters down in DC, what are you doing? Have some coffee Pharmalot -style, then get on that.

261

261

Pharmaceutical Technology

OCTOBER 24, 2024

Novo Nordisk has asked the FDA to add semaglutide to a list that would effectively block manufacturing of copycat versions of Wegovy and Ozempic.

90

90

STAT

OCTOBER 24, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Are health AI businesses zooming? In a new report , Bessemer Venture Partners unpacks early insights about the prospects for artificial intelligence software services businesses it sees as a new category in the broader health tech ecosystem.

275

275

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

PharmaTech

OCTOBER 24, 2024

Laks Pernenkil, Brian Feth, and Alex Philippidis go behind the headlines to discuss the impact of recent news, including FDA’s drug shortage list update, Nobel prize winners in microRNA and AI, and a big-potential research win for RNA editing.

75

75

pharmaphorum

OCTOBER 24, 2024

WhatsApp message earns Moderna a reprimand under the ABPI Code, with Novo Nordisk, Otsuka, AstraZeneca and Daiichi Sankyo also breaching the rules

105

105

BioPharma Dive

OCTOBER 24, 2024

The deal will give Lyell a dual-targeting CAR-T candidate for blood cancers. Relatedly, Lyell has opted to end development of two current pipeline programs.

81

81

World Pharma News

OCTOBER 24, 2024

New research from biologists at the USC Dornsife College of Letters, Arts and Sciences reveals that mifepristone, a drug best known for its use for ending early pregnancies, might also extend lifespan. The findings could pave the way for anti-aging treatments. Mifepristone, which is also used to treat Cushing's disease and certain cancers, has caught the attention of scientists exploring ways to promote longer, healthier lives.

84

84

pharmaphorum

OCTOBER 24, 2024

Explore the future of drug development by integrating open source and commercial software. Learn how this innovative approach is revolutionising the field of drug discovery.

Drug Development 93

Drug Development 93